SEC Form 4 · accession 0001209191-18-033337
NANOPHASE TECHNOLOGIES Corp · NANX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
George A Vincent
Director
Period of report
Sep 3, 2014
Accepted (ET)
May 25, 2018 · 10:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 3, 2014 | P | 20,618 | $0.51 | A | 20,618 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (right to purchase)F2 | $0.82 | May 23, 2018 | A | 10,000 | A | May 23, 2019 | May 23, 2028 | Common Stock | 10,000 | 10,000 | D |
| Common Stock (right to purchase)F2 | $1.36 | holding | — | — | — | Jan 31, 2012 | Jan 31, 2021 | Common Stock | 12,000 | 12,000 | D |
| Deferred Common StockF3,F4,F5 | — | holding | — | — | — | — | — | Common Stock | 2,250 | 12,652 | D |
| Common Stock (right to purchase)F2 | $0.30 | holding | — | — | — | Aug 7, 2013 | Aug 7, 2022 | Common Stock | 12,000 | 12,000 | D |
| Common Stock (right to purchase)F2 | $0.415 | holding | — | — | — | Feb 14, 2014 | Feb 14, 2023 | Common Stock | 10,000 | 10,000 | D |
| Common Stock (right to purchase)F2 | $0.52 | holding | — | — | — | Feb 13, 2015 | Feb 13, 2024 | Common Stock | 10,000 | 10,000 | D |
| Common Stock (right to purchase)F2 | $0.44 | holding | — | — | — | Feb 18, 2016 | Feb 18, 2025 | Common Stock | 9,000 | 9,000 | D |
| Common Stock (right to purchase)F2 | $0.42 | holding | — | — | — | Feb 23, 2017 | Feb 23, 2026 | Common Stock | 8,100 | 8,100 | D |
| Common Stock (right to purchase)F6 | $0.90 | holding | — | — | — | Nov 17, 2016 | Nov 17, 2026 | Common Stock | 2,250 | 2,250 | D |
| Common Stock (right to purchase)F6 | $1.05 | holding | — | — | — | Nov 17, 2016 | Nov 17, 2026 | Common Stock | 2,250 | 2,250 | D |
| Common Stock (right to purchase)F6 | $1.18 | holding | — | — | — | Nov 17, 2016 | Nov 17, 2026 | Common Stock | 2,250 | 2,250 | D |
| Common Stock (right to purchase)F6 | $0.84 | holding | — | — | — | Nov 17, 2016 | Nov 17, 2026 | Common Stock | 2,250 | 2,250 | D |
| Common Stock (right to purchase)F6 | $1.85 | holding | — | — | — | Nov 17, 2016 | Nov 17, 2026 | Common Stock | 2,250 | 2,250 | D |
| Common Stock (right to purchase)F6 | $1.10 | holding | — | — | — | Nov 17, 2016 | Nov 17, 2026 | Common Stock | 2,250 | 2,250 | D |
| Common Stock (right to purchase)F6 | $0.99 | holding | — | — | — | Nov 17, 2016 | Nov 17, 2026 | Common Stock | 2,250 | 2,250 | D |
| Common Stock (right to purchase)F2 | $0.68 | holding | — | — | — | Feb 21, 2018 | Feb 21, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1These shares of common stock were purchased in the open market during an open trading window for Company officers and directors. The Form 4s filed by the reporting person after September 3, 2014 and prior to the date of this Form 4 did not reflect these shares as being owned by the reporting person.
- F2Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
- F3Each share of deferred common stock represents a right to receive one share of common stock.
- F4The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
- F5Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 12,652 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
- F6The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued with exercise prices equal to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99.